Bioavailability of Polyphenols and Flavonoids in the Era of Precision Medicine

Molecular Pharmaceutics

Volumn 14, Issue 9, 2017, Pages 2861-2863

  Hu, Ming ^a   Wu, Baojian ^b   Liu, Zhongqiu ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b JINAN UNIVERSITY   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; FLAVONOID; GENISTEIN; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; NUTRITION SUPPLEMENT; OLEATE SODIUM; POLYPHENOL; RESVERATROL; SULFATE; SULFOTRANSFERASE;

DIETARY SUPPLEMENT; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG GLUCURONIDATION; EDITORIAL; HUMAN; NANOEMULSION; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SULFONATION; METABOLISM; PROCEDURES;

FLAVONOIDS; HUMANS; POLYPHENOLS; PRECISION MEDICINE;

EID: 85028890081     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.7b00545     Document Type: Editorial

References (29)

1. Hu, M. Commentary: bioavailability of flavonoids and polyphenols: call to arms Mol. Pharmaceutics 2007, 4 (6) 803-6 10.1021/mp7001363
2. Farzaei, M. H.; Rahimi, R.; Abdollahi, M. The role of dietary polyphenols in the management of inflammatory bowel disease Curr. Pharm. Biotechnol. 2015, 16 (3) 196-210 10.2174/1389201016666150118131704
3. Amiot, M. J.; Riva, C.; Vinet, A. Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review Obes. Rev. 2016, 17 (7) 573-86 10.1111/obr.12409
4. Lall, R. K.; Syed, D. N.; Adhami, V. M.; Khan, M. I.; Mukhtar, H. Dietary polyphenols in prevention and treatment of prostate cancer Int. J. Mol. Sci. 2015, 16 (2) 3350-76 10.3390/ijms16023350
5. Quideau, S.; Deffieux, D.; Douat-Casassus, C.; Pouységu, L. Plant polyphenols: chemical properties, biological activities, and synthesis Angew. Chem., Int. Ed. 2011, 50 (3) 586-621 10.1002/anie.201000044
6. Zduńczyk, Z.; Juśkiewicz, J.; Estrella, I. Cecal parameters of rats fed diets containing grapefruit polyphenols and inulin as single supplements or in a combination Nutrition 2006, 22 (9) 898-904 10.1016/j.nut.2006.05.010
7. Rodrigo, R.; Libuy, M.; Feliu, F.; Hasson, D. Polyphenols in disease: from diet to supplements Curr. Pharm. Biotechnol. 2014, 15 (4) 304-17 10.2174/138920101504140825113815
8. Park, S. J.; Ahmad, F.; Philp, A.; Baar, K.; Williams, T.; Luo, H.; Ke, H.; Rehmann, H.; Taussig, R.; Brown, A. L.; Kim, M. K.; Beaven, M. A.; Burgin, A. B.; Manganiello, V.; Chung, J. H. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases Cell 2012, 148 (3) 421-33 10.1016/j.cell.2012.01.017
9. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies Am. J. Clin. Nutr. 2005, 81 (1 Suppl.) 243S-255S
10. Wu, B.; Kulkarni, K.; Basu, S.; Zhang, S.; Hu, M. first-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics J. Pharm. Sci. 2011, 100 (9) 3655-81 10.1002/jps.22568
11. Wu, B.; Basu, S.; Meng, S.; Wang, X.; Hu, M. Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis Curr. Drug Metab. 2011, 12 (9) 900-16 10.2174/138920011797470100
12. Rowland, A.; Miners, J. O.; Mackenzie, P. I. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification Int. J. Biochem. Cell Biol. 2013, 45 (6) 1121-32 10.1016/j.biocel.2013.02.019
13. Xu, H.; Kulkarni, K. H.; Singh, R.; Yang, Z.; Wang, S. W.; Tam, V. H.; Hu, M. Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides Mol. Pharmaceutics 2009, 6 (6) 1703-15 10.1021/mp900013d
14. Yang, Z.; Zhu, W.; Gao, S.; Yin, T.; Jiang, W.; Hu, M. Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein Drug Metab. Dispos. 2012, 40 (10) 1883-93 10.1124/dmd.111.043901
15. Quan, E.; Wang, H.; Dong, D.; Zhang, X.; Wu, B. Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide Drug Metab. Dispos. 2015, 43 (4) 433-43 10.1124/dmd.114.061598
16. Wang, S.; Xing, H.; Zhao, M.; Lu, D.; Li, Z.; Dong, D.; Wu, B. Recent Advances in Understanding of Kinetic Interplay Between Phase II Metabolism and Efflux Transport Curr. Drug Metab. 2016, 17 (10) 922-929 10.2174/1389200217666161128150835
17. Sun, H.; Zhou, X.; Zhang, X.; Wu, B. Decreased Expression of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Leads to Reduced Glucuronidation of Flavonoids in UGT1A1-Overexpressing HeLa Cells: The Role of Futile Recycling J. Agric. Food Chem. 2015, 63 (26) 6001-8 10.1021/acs.jafc.5b00983
18. Zhao, M.; Wang, S.; Li, F.; Dong, D.; Wu, B. Arylsulfatase B Mediates the Sulfonation-Transport Interplay in Human Embryonic Kidney 293 Cells Overexpressing Sulfotransferase 1A3 Drug Metab. Dispos. 2016, 44 (9) 1441-9 10.1124/dmd.116.070938
19. Pogacnik, L.; Pirc, K.; Palmela, I.; Skrt, M.; Kim, K. S.; Brites, D.; Brito, M. A.; Ulrih, N. P.; Silva, R. F. Potential for brain accessibility and analysis of stability of selected flavonoids in relation to neuroprotection in vitro Brain Res. 2016, 1651, 17-26 10.1016/j.brainres.2016.09.020
20. Andrade, P. B.; Grosso, C.; Valentao, P.; Bernardo, J. Flavonoids in Neurodegeneration: Limitations and Strategies to Cross CNS Barriers Curr. Med. Chem. 2016, 23 (36) 4151-4174 10.2174/0929867323666160809094934
21. Dong, D.; Ako, R.; Hu, M.; Wu, B. Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes Xenobiotica 2012, 42 (8) 808-20 10.3109/00498254.2012.663515
22. Sharma, V.; Duffel, M. W. A comparative molecular field analysis-based approach to prediction of sulfotransferase catalytic specificity Methods Enzymol. 2005, 400, 249-63 10.1016/S0076-6879(05)00014-5
23. Wei, Y.; Wu, B.; Jiang, W.; Yin, T.; Jia, X.; Basu, S.; Yang, G.; Hu, M. Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells Mol. Pharmaceutics 2013, 10 (5) 1736-50 10.1021/mp300562q
24. Williamson, G.; Aeberli, I.; Miguet, L.; Zhang, Z.; Sanchez, M. B.; Crespy, V.; Barron, D.; Needs, P.; Kroon, P. A.; Glavinas, H.; Krajcsi, P.; Grigorov, M. Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2) Drug Metab. Dispos. 2007, 35 (8) 1262-8 10.1124/dmd.106.014241
25. Hu, D. G.; Meech, R.; McKinnon, R. A.; Mackenzie, P. I. Transcriptional regulation of human UDP-glucuronosyltransferase genes Drug Metab. Rev. 2014, 46 (4) 421-58 10.3109/03602532.2014.973037
26. Kodama, S.; Negishi, M. Sulfotransferase genes: regulation by nuclear receptors in response to xeno/endo-biotics Drug Metab. Rev. 2013, 45 (4) 441-9 10.3109/03602532.2013.835630
27. Riches, Z.; Collier, A. C. Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases Expert Opin. Drug Metab. Toxicol. 2015, 11 (6) 949-65 10.1517/17425255.2015.1028355
28. Klaassen, C. D.; Aleksunes, L. M. Xenobiotic, bile acid, and cholesterol transporters: function and regulation Pharmacol Rev. 2010, 62 (1) 1-96 10.1124/pr.109.002014
29. Margina, D.; Ilie, M.; Gradinaru, D.; Androutsopoulos, V. P.; Kouretas, D.; Tsatsakis, A. M. Natural products-friends or foes? Toxicol. Lett. 2015, 236 (3) 154-67 10.1016/j.toxlet.2015.05.009